Advanced Search

 

Study ID Status Title Patient Level Data
113519 Completed Immunogenicity and safety study of GSK Biologicals’ influenza candidate vaccine GSK2340274A Study Listed on ClinicalStudyDataRequest.com
113525 Completed Immunogenicity, safety and reactogenicity of GSK Biologicals’ influenza GSK2340272A and Fluarix™ 2009-2010 vaccines when co-administered in elderly subjects aged 61 years and older Study Listed on ClinicalStudyDataRequest.com
113528 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
113535 Completed Immunological equivalence between GSK2340272A and GSK2340274A influenza vaccines in adults aged 18 to 60 years Study Listed on ClinicalStudyDataRequest.com
113536 Completed A study to evaluate the safety and immunogenicity of an A/California/7/2009 (H1N1)v-like vaccine GSK2340274A or GSK2340273A co-administered with trivalent inactivated seasonal influenza vaccine in adults 19 to 40 years of age Study Listed on ClinicalStudyDataRequest.com
113545 Completed Reactogenicity and safety of a single dose of GlaxoSmithKline (GSK) Biologicals’ human rotavirus (HRV) vaccine (444563) in healthy adults Study Listed on ClinicalStudyDataRequest.com
113552 Completed Reactogenicity and safety of a single dose of GlaxoSmithKline (GSK) Biologicals’ human rotavirus (HRV) vaccine (444563) in healthy children Study Listed on ClinicalStudyDataRequest.com
113555 Completed A two-part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat oral doses of pazopanib in healthy adult subjects
113572 Completed Immunogenicity and safety of GSK Biologicals’ pandemic influenza candidate vaccine GSK2340272A Study Listed on ClinicalStudyDataRequest.com
113574 Completed Safety and Immunogenicity Study of GSK Biologicals' Influenza Vaccine GSK2340272A in Adults Aged 18 to 60 Years Study Listed on ClinicalStudyDataRequest.com
113583 Completed An Open-Label, Multi-Center Study to Investigate the Objective Response Rate, Safety, and Pharmacokinetics of GSK1120212, a MEK Inhibitor, in BRAF Mutation-positive Melanoma Subjects Previously Treated with or without a BRAF Inhibitor
113585 Completed Post-Authorization Safety Study (PASS) of GlaxoSmithKline Biologicals’ pandemic influenza vaccine (GSK2340272A) in the United Kingdom (UK)
113589 Completed A randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of GSK573719 delivered once-daily over 28 days in subjects with COPD Study Listed on ClinicalStudyDataRequest.com
113615 Completed Feasibility study of GlaxoSmithKline Biologicals’ GSK2202083A vaccine in healthy infants at 2, 4 and 12 months of age Study Listed on ClinicalStudyDataRequest.com
113625 Completed A Randomized, Placebo Controlled, 3-Way Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo 10mg Administered Twice Daily for 5 Days by a Rotahaler Compared to the Diskhaler in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
113629 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 8 to 12 weeks Study Listed on ClinicalStudyDataRequest.com
113630 Completed Safety and immunogenicity study of GSK Biologicals’ influenza vaccine GSK2340272A in adults aged 18 years and above Study Listed on ClinicalStudyDataRequest.com
113637 Completed Observational study to monitor the introduction of flixotide evohaler in the United Kingdom
113638 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
113642 Completed Seretide Evohaler PEM study
113656 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_1 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_2 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_3 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_4 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.